1. Home
  2. CAE vs LEGN Comparison

CAE vs LEGN Comparison

Compare CAE & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAE
  • LEGN
  • Stock Information
  • Founded
  • CAE 1947
  • LEGN 2014
  • Country
  • CAE Canada
  • LEGN United States
  • Employees
  • CAE N/A
  • LEGN N/A
  • Industry
  • CAE
  • LEGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAE
  • LEGN Health Care
  • Exchange
  • CAE Nasdaq
  • LEGN Nasdaq
  • Market Cap
  • CAE 8.1B
  • LEGN 7.0B
  • IPO Year
  • CAE N/A
  • LEGN 2020
  • Fundamental
  • Price
  • CAE $25.98
  • LEGN $31.08
  • Analyst Decision
  • CAE Buy
  • LEGN Strong Buy
  • Analyst Count
  • CAE 3
  • LEGN 13
  • Target Price
  • CAE $32.00
  • LEGN $79.42
  • AVG Volume (30 Days)
  • CAE 419.8K
  • LEGN 1.6M
  • Earning Date
  • CAE 05-13-2025
  • LEGN 05-13-2025
  • Dividend Yield
  • CAE N/A
  • LEGN N/A
  • EPS Growth
  • CAE N/A
  • LEGN N/A
  • EPS
  • CAE N/A
  • LEGN N/A
  • Revenue
  • CAE $3,168,385,644.00
  • LEGN $728,303,000.00
  • Revenue This Year
  • CAE $11.49
  • LEGN $65.96
  • Revenue Next Year
  • CAE $6.91
  • LEGN $52.55
  • P/E Ratio
  • CAE N/A
  • LEGN N/A
  • Revenue Growth
  • CAE 4.71
  • LEGN 112.46
  • 52 Week Low
  • CAE $15.95
  • LEGN $29.27
  • 52 Week High
  • CAE $27.62
  • LEGN $60.87
  • Technical
  • Relative Strength Index (RSI)
  • CAE 62.48
  • LEGN 39.41
  • Support Level
  • CAE $25.38
  • LEGN $30.25
  • Resistance Level
  • CAE $26.10
  • LEGN $33.30
  • Average True Range (ATR)
  • CAE 0.52
  • LEGN 1.53
  • MACD
  • CAE 0.17
  • LEGN -0.18
  • Stochastic Oscillator
  • CAE 77.82
  • LEGN 26.21

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a global training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: